---
figid: PMC5220330__fimmu-07-00682-g001
figlink: /pmc/articles/PMC5220330/figure/F1/
number: Figure 1
caption: Interleukin-33 (IL-33)/ST2 signaling pathway. IL-33 is mainly expressed in
  the nucleus of epithelial and endothelial cells. IL-33 is released subsequent to
  cell damage, stress, or necrosis. Alternatively, IL-33 may be released under steady-state
  conditions—at low levels—via a so far unknown mechanism. Soluble IL-33 binds to
  its receptor, a heterodimeric complex comprising IL-1RL1/ST2 (ST2) and IL-1 receptor
  accessory protein (IL1RAP), thereby mobilizing downstream signaling molecules including
  MyD88 and TRAF-6, and eventually activating NF-κB, p38, JNK, and ERK pathways. Soluble
  ST2 acts as a decoy receptor for IL-33 to negatively regulate IL-33/ST2 signaling.
pmcid: PMC5220330
papertitle: The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.
reftext: Marie-Hélène Wasmer, et al. Front Immunol. 2016;7:682.
pmc_ranked_result_index: '73500'
pathway_score: 0.7647083
filename: fimmu-07-00682-g001.jpg
figtitle: Interleukin-33 (IL-33)/ST2 signaling pathway
year: '2016'
organisms: Homo sapiens
ndex: 78602a23-df2a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5220330__fimmu-07-00682-g001.html
  '@type': Dataset
  description: Interleukin-33 (IL-33)/ST2 signaling pathway. IL-33 is mainly expressed
    in the nucleus of epithelial and endothelial cells. IL-33 is released subsequent
    to cell damage, stress, or necrosis. Alternatively, IL-33 may be released under
    steady-state conditions—at low levels—via a so far unknown mechanism. Soluble
    IL-33 binds to its receptor, a heterodimeric complex comprising IL-1RL1/ST2 (ST2)
    and IL-1 receptor accessory protein (IL1RAP), thereby mobilizing downstream signaling
    molecules including MyD88 and TRAF-6, and eventually activating NF-κB, p38, JNK,
    and ERK pathways. Soluble ST2 acts as a decoy receptor for IL-33 to negatively
    regulate IL-33/ST2 signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB1
  - MAPK3
  - MYD88
  - MAPK8
  - IL1RAP
  - MAPK1
  - MAPK11
  - IL33
  - IRAK1
  - MAPK10
  - TRAF6
  - MAPK13
  - MAPK14
  - SDCBP2
  - MAPK9
  - IRAK4
  - MAPK12
genes:
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: IL-1RAP
  symbol: IL1RAP
  source: hgnc_symbol
  hgnc_symbol: IL1RAP
  entrez: '3556'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: IL-33
  symbol: IL33
  source: hgnc_symbol
  hgnc_symbol: IL33
  entrez: '90865'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: ST2
  symbol: ST-2
  source: hgnc_alias_symbol
  hgnc_symbol: SDCBP2
  entrez: '27111'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
chemicals: []
diseases: []
---
